ANTIBODY-MEDIATED REJECTION
Clinical trials for ANTIBODY-MEDIATED REJECTION explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY-MEDIATED REJECTION trials appear
Sign up with your email to follow new studies for ANTIBODY-MEDIATED REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for transplant patients: new drug shows promise in Long-Term rejection fight
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of felzartamab in people who have had a kidney transplant and developed antibody-mediated rejection (AMR), where the immune system attacks the new kidney. Participants who completed an earlier study can receive felzartamab for up to 4 more…
Matched conditions: ANTIBODY-MEDIATED REJECTION
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Gene clues could improve treatment for organ rejection
Knowledge-focused OngoingThis study looks at gene activity in blood cells from 30 kidney or lung transplant patients who have chronic rejection. Researchers want to find out why some patients respond well to a treatment called extracorporeal photoapheresis (ECP) while others do not. By comparing gene pro…
Matched conditions: ANTIBODY-MEDIATED REJECTION
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 26, 2026 02:03 UTC
-
Pee power: urine test may spare kids painful kidney biopsies
Knowledge-focused OngoingThis study checks if certain substances in urine can tell doctors whether a child's kidney transplant is being rejected. About 445 children aged 2 to 18 who have a kidney transplant and need a biopsy will provide urine samples. The goal is to see if these urine tests are as accur…
Matched conditions: ANTIBODY-MEDIATED REJECTION
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC